LXRX
Lexicon Pharmaceuticals Regains Compliance with Nasdaq Minimum Bid Price Requirement
Thursday, July 31, 2025 1 min read
Key Takeaway: Lexicon Pharmaceuticals Regains Compliance with Nasdaq Minimum Bid Price Requirement
Full Press Release Details
Lexicon Pharmaceuticals Regains Compliance with Nasdaq Minimum Bid Price Requirement.